Mersana Therapeutics, Inc. Restricted Cash, Current
Mersana Therapeutics, Inc. had Restricted Cash, Current of $478.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2025-11-14
- 2025-09-30: Restricted Cash, Current $478.00K.
- 2025-06-30: Restricted Cash, Current $478.00K.
- 2025-03-31: Restricted Cash, Current $321.00K.
- 2024-12-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2025-09-30 | $478.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $478.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $321.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-14 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2023-12-31 | $0.00 10-Q · filed 2025-11-14 |